Beijing, China

Hongda Li

This inventor holds 3 USPTO granted patents. Top assignees: Beihang University, Beijing Information Science & Technology University, Beijing Institute of Technology. Active years: 2011-2025.


% Patents Active = 66.7

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2011-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Hongda Li

Introduction

Hongda Li is a prominent inventor based in Beijing, China. He has made significant contributions to the field of radiotherapy and has been awarded 3 patents for his innovative work. His inventions focus on improving the accuracy and efficiency of medical treatments.

Latest Patents

One of his latest patents is the "Image guided radiotherapy apparatus and control method therefor." This invention includes a treatment unit with a treatment head that generates a radiation beam for radiotherapy. Additionally, it features an imaging unit that is integrated with the treatment head to image the target area of a patient. This radiotherapy apparatus is applicable to both extracorporeal and intraoperative radiotherapy, ensuring high radiotherapy accuracy.

Career Highlights

Throughout his career, Hongda Li has worked with notable companies such as Honeywell (China) Co., Ltd. and Honeywell International Inc. His experience in these organizations has contributed to his expertise in developing advanced medical technologies.

Collaborations

Hongda Li has collaborated with several professionals in his field, including Ke Zhang and Yongkui Yu. These collaborations have fostered innovation and have led to the development of cutting-edge technologies in radiotherapy.

Conclusion

Hongda Li's contributions to the field of radiotherapy through his patents and collaborations highlight his role as a key innovator in medical technology. His work continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…